A system of photosensitive retinal ganglion cells provides ‘non-visual’ information on the circadian sequences of light to the suprachiasmatic nucleus (SCN), which, as the ‘master clock’, synchronizes the chronobiological mechanisms of all the biological clocks. Damage to SCN structure alters circadian behavioral and hormonal rhythms and interferes with a regular sleep-wake pattern. Several studies have shown that, in aging and in Alzheimer’s disease (AD), circadian rhythms change their synchronization with the environment and behavior loses sync with light.
Objective:
The current overview aims to examine research studies showing the effect of bright light therapy (BLT) on sleep disorders and sleep-wake patterns in AD.
Methods:
A literature search was conducted, taking into consideration the relevant studies over the last 20 years. Fifteen studies have been thorough: seven followed an environmental-architectural approach and eight followed a treatment devices approach.
Results:
Studies agree in considering BLT as a promising non-pharmacological intervention to compensate for circadian rhythm alterations and they support the need for standardized protocols that allow a comparison between multicenter studies.
Conclusion:
Interestingly, in an attempt to contain the spread of the COVID-19 pandemic, health authorities have forced the population to stay home. Therefore, AD people are not currently able to enjoy exposure to sunlight. It is predictable that they may experience an exacerbation of circadian disturbances and that the BLT can be an effective response to prevent such exacerbation.
HalbergF (1969) Chronobiology. Annu Rev Physiol31, 675–726.
2.
BersonDM, DunnFA, TakaoM (2002) Phototransduction by retinal ganglion cells that set the circadian clock. Science295, 1070–1073.
3.
HattarS, LucasRJ, MrosovskyN, ThompsonS, DouglasRH, HankinsMW, LemJ, BielM, HofmannF, FosterRG (2003) Melanopsin and rod–cone photoreceptive systems account for all major accessory visual functions in mice. Nature424, 75–81.
4.
RamkisoensingA, MeijerJH (2015) Synchronization of biological clock neurons by light and peripheral feedback systems promotes circadian rhythms and health. Front Neurol6, 128.
5.
WeaverDR (1998) The suprachiasmatic nucleus: A 25-year retrospective. J Biol Rhythms13, 100–112.
6.
StephanFK, ZuckerI (1972) Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions (suprachiasmatic and medial preoptic nuclei/retino-hypothalamic projection). Proc Natl Acad Sci U S A69, 1583–1586.
7.
WaltonJC, WeilZM, NelsonRJ (2011) Influence of photoperiod on hormones, behavior, and immune function. Front Neuroendocrinol32, 303–319.
8.
GrandinLD, AlloyLB, AbramsonLY (2006) The social zeitgeber theory, circadian rhythms, and mood disorders: Review and evaluation. Clin Psychol Rev26, 679–694.
9.
BaronKG, ReidKJ (2014) Circadian misalignment and health. Int Rev Psychiatry26, 139–154.
Van SomerenEJW (2000) Circadian and sleep disturbances in the elderly. Exp Gerontol35, 1229–1237.
12.
SwaabDF, Grundke-IqbalI, IqbalK, KremerHPH, RavidR, Van de NesJAP (1992) τ and ubiquitin in the human hypothalamus in aging and Alzheimer’s disease. Brain Res590, 239–249.
13.
HofmanMA (2000) The human circadian clock and aging. Chronobiol Int17, 245–259.
14.
SwaabDF, FliersE, PartimanTS (1985) The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res342, 37–44.
15.
WittingW, KwaIH, EikelenboomP, MirmiranM, SwaabDF (1990) Alterations in the circadian rest-activity rhythm in aging and Alzheimer’s disease. Biol Psychiatry27, 563–572.
16.
LinL, HuangQ-X, YangS-S, ChuJ, WangJ-Z, TianQ (2013) Melatonin in Alzheimer’s disease. Int J Mol Sci14, 14575–14593.
17.
WhiteMD, Ancoli-IsraelS, WilsonRR (2013) Senior living environments: Evidence-based lighting design strategies. HERD Heal Environ Res Des J7, 60–78.
18.
Riemersma-Van Der LekRF, SwaabDF, TwiskJ, HolEM, HoogendijkWJG, Van SomerenEJW (2008) Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: A randomized controlled trial. JAMA299, 2642–2655.
19.
LandryGJ, Liu-AmbroseT (2014) Buying time: A rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer’s disease. Front Aging Neurosci6, 325.
20.
SrinivasanV, KaurC, Pandi-PerumalS, BrownGM, CardinaliDP (2011) Melatonin and its agonist ramelteon in Alzheimer’s disease: Possible therapeutic value. Int J Alzheimers Dis2011, 741974.
LeGatesTA, FernandezDC, HattarS (2014) Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci15, 443–454.
23.
ParryBL, MahanAM, MostofiN, KlauberMR, LewGS, GillinJC (1993) Light therapy of late luteal phase dysphoric disorder: An extended study. Am J Psychiatry150, 1417–1419.
24.
LamRW, CarterD, MisriS, KuanAJ, YathamLN, ZisAP (1999) A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res86, 185–192.
25.
LamRW, GoldnerEM, SolyomL, RemickRA (1994) A controlled study of light therapy for bulimia nervosa. Am J Psychiatry151, 744–750.
26.
BraunDL, SundaySR, FornariVM, HalmiKA (1999) Bright light therapy decreases winter binge frequency in women with bulimia nervosa: A double-blind, placebo-controlled study. Compr Psychiatry40, 442–448.
27.
OrenDA, WisnerKL, SpinelliM, EppersonCN, PeindlKS, TermanJS, TermanM (2002) An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry159, 666–669.
28.
Wirz-JusticeA, BaderA, FrischU, StieglitzR-D, AlderJ, BitzerJ, HösliI, JazbecS, BenedettiF, TermanM, WisnerKL, Riecher-RösslerA (2011) A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry72, 986–993.
29.
CorralM, KuanA, KostarasD (2000) Bright light therapy’s effect on postpartum depression. Am J Psychiatry157, 303–304.
30.
CorralM, WardropAA, ZhangH, GrewalAK, PattonS (2007) Morning light therapy for postpartum depression. Arch Womens Ment Health10, 221–224.
31.
YamaderaH, ItoT, SuzukiH, AsayamaK, ItoR, EndoS (2000) Effects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementia. Psychiatry Clin Neurosci54, 352–353.
32.
OnegaLL, PierceTW, EpperlyL (2018) Bright light therapy to treat depression in individuals with mild/moderate or severe dementia. Issues Ment Health Nurs39, 370–373.
33.
BurnsA, AllenH, TomensonB, DuignanD, ByrneJ (2009) Bright light therapy for agitation in dementia: A randomized controlled trial. Int Psychogeriatrics21, 711–721.
34.
MostEIS, ScheltensP, Van SomerenEJW (2010) Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial. Trials11, 19.
35.
FigueiroMG, PlitnickBA, LokA, JonesGE, HigginsP, HornickTR, ReaMS (2014) Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilities. Clin Interv Aging9, 1527.
36.
FigueiroMG, HunterCM, HigginsPA, HornickTR, JonesGE, PlitnickB, BronsJ, ReaMS (2015) Tailored lighting intervention for persons with dementia and caregivers living at home. Sleep Health1, 322–330.
37.
SekiguchiH, IritaniS, FujitaK (2017) Bright light therapy for sleep disturbance in dementia is most effective for mild to moderate Alzheimer’s type dementia: A case series. Psychogeriatrics17, 275–281.
38.
van Lieshout-van DalE, SnaphaanL, BongersI (2019) Biodynamic lighting effects on the sleep pattern of people with dementia. Build Environ150, 245–253.
39.
McCurrySM, PikeKC, VitielloMV, LogsdonRG, LarsonEB, TeriL (2011) Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer’s disease: Results of a randomized, controlled trial. J Am Geriatr Soc59, 1393–1402.
40.
OnegaLL, PierceTW, EpperlyL (2016) Effect of bright light exposure on depression and agitation in older adults with dementia. Issues Ment Health Nurs37, 660–667.
41.
HickmanSE, BarrickAL, WilliamsCS, ZimmermanS, ConnellBR, PreisserJS, Madeline MitchellC, SloanePD (2007) The effect of ambient bright light therapy on depressive symptoms in persons with dementia. J Am Geriatr Soc55, 1817–1824.
42.
LyketsosCG, Lindell VeielL, BakerA, SteeleC (1999) A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int J Geriatr Psychiatry14, 520–525.
43.
HangerMA, Ancoli-IsraelS, KripkeDF, JonesDW, AlmendarezL (1992) Effect of phototherapy on depression in nursing home residents. Sleep Res21, 88.
44.
BarrickAL, SloanePD, WilliamsCS, MitchellCM, ConnellBR, WoodW, HickmanSE, PreisserJS, ZimmermanS (2010) Impact of ambient bright light on agitation in dementia. Int J Geriatr Psychiatry25, 1013–1021.
45.
SloanePD, FigueiroM, GargS, CohenLW, ReedD, WilliamsCS, PreisserJ, ZimmermanS (2015) Effect of home-based light treatment on persons with dementia and their caregivers. Light Res Technol47, 161–176.
46.
Van SomerenEJW, KesslerA, MirmiranM, SwaabDF (1997) Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry41, 955–963.
47.
Ancoli-IsraelS, MartinJL, KripkeDF, MarlerM, KlauberMR (2002) Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc50, 282–289.
48.
Ancoli-IsraelS, GehrmanP, MartinJL, ShochatT, MarlerM, Corey-BloomJ, LeviL (2003) Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav Sleep Med1, 22–36.
49.
SmirniD, SmirniP, Di MartinoG, CipolottiL, OliveriM, TurrizianiP (2018) Standardization and validation of a parallel form of the verbal and non-verbal recognition memory test in an Italian population sample. Neurol Sci39, 1391–1399.
50.
SmirniD, SmirniP, Di MartinoG, FontanaML, CipolottiL, OliveriM, TurrizianiP (2019) Early detection of memory impairments in older adults: Standardization of a short version of the verbal and nonverbal Recognition Memory Test. Neurol Sci40, 97–103.
